Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2000
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2370267A1 Prodrugs of thrombin inhibitors
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2369822A1 Novel human voltage-gated potassium channel
10/19/2000CA2369728A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000CA2369691A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000CA2369662A1 Prostaglandin e1 derivatives
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369454A1 Uses of mammalian ox2 protein and related reagents
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369103A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000CA2368937A1 Prevention of brain damage in stroke
10/19/2000CA2368840A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
10/19/2000CA2368049A1 Integrin receptor ligands
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2364690A1 Novel transduction molecules and methods for using same
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/18/2000EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them
10/18/2000EP1044206A1 Prodrugs of naaladase inhibitors
10/18/2000EP1044203A1 3'-epimeric k-252a derivatives
10/18/2000EP1044202A1 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides
10/18/2000EP1044200A1 Preparation of terazosin hydrochloride dihydrate
10/18/2000EP1044189A1 Aryl fused azapolycyclic compounds
10/18/2000EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
10/18/2000EP1044009A2 Methods and compositions employing red rice fermentation products
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP1043997A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP1043983A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000CN1270591A Novel compounds
10/18/2000CN1270590A Novel compounds
10/18/2000CN1270585A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/18/2000CN1270169A Benzopyrane derivatives and preparation thereof
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/18/2000CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270045A Chinese patent medicine for treating hemicrania-type diseases caused by cerebral vessal
10/18/2000CN1270038A Fumigant lotion for treating anorectal disease and preparing process thereof
10/18/2000CN1270031A Oral liquid of sodium fructose-biphosphate and preparing process thereof
10/18/2000CN1057522C Naphthalene derivs. as prostaglandin I2 agonists
10/17/2000US6133479 Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/17/2000US6133446 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133315 Administering to treat pancreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation in a mammal; compounds such as 2-chlorobenzenesulfonic acid 3-(3-amidinopropoxy)-5-methylphenyl ester hydrochloride
10/17/2000US6133311 Method for preventing or treating elevated blood lipid level-related diseases by administering natural phenolic compounds
10/17/2000US6133304 Treating fibrosis, ventricular dilation, and/or heart failure in a mammal by administering an antifibrotic amount of a mixture of an angiotensin-converting enzyme(ace) inhibitor and at least one matrix metalloproteinase(mmp) inhibitor
10/17/2000US6133303 Various indene derivatives, with the exception of 5-(2-imidazole-1-yl-ethoxy)indan-1-one; treating cancer and treating or preventing restenosis or atherosclerosis
10/17/2000US6133291 3-(piperidin-1-ylalkylene)imidazole derivatives; glaucoma, antiallergens; antiinflammation and hypotensive agents, sleeping disorders; hypermotility of the gastrointestinal tract, alzheimer's disease, schizophrenia and
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133270 Isothiazolones and pharmaceutical formulations
10/17/2000US6133267 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/17/2000US6133265 Treating physiological disorders associated with an excess of neuropeptide y, such as eating disorders, e.g., obesity, bulimia, and certain cardiovascular diseases, e.g., hypertension
10/17/2000US6133261 Amino acid derivatives useful to treat stroke
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6133256 Selective factor Xa inhibitors
10/17/2000US6133240 Tetrahydronapthalene derivatives and their therapeutic use
10/17/2000US6133031 Antisense inhibition of focal adhesion kinase expression
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132965 Detecting premature atherosclerosis in humans; screening humans for amplified levels of serum homocysteine and comparing to control
10/17/2000US6132715 Method of inhibiting biosynthesis of tumor necrosis factor
10/17/2000US6131578 Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2305893A1 Use of maduraphthalazine derivatives as inhibitors of proinflammatory cytokines
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/15/2000CA2305940A1 Aminotriazol compounds, the process for preparing them and the pharmaceutical compositions containing them
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery
10/12/2000WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059940A2 Platelet-derived growth factor related gene and protein
10/12/2000WO2000059921A1 Preparation of saturated phytosterols
10/12/2000WO2000059913A1 Novel thiazolobenzimidazole derivatives
10/12/2000WO2000059912A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
10/12/2000WO2000059907A2 Pyrazolotriazines as crf antagonists
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059889A1 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
10/12/2000WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000WO2000059855A1 Ether compounds, compositions, and uses thereof
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059535A2 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
10/12/2000WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES
10/12/2000WO2000059520A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000WO2000059511A1 Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
1 ... 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 ... 1595